4.4 Review

Evolutionary trajectory of leukemic clones and its clinical implications

期刊

HAEMATOLOGICA
卷 104, 期 5, 页码 872-880

出版社

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2018.195289

关键词

-

向作者/读者索取更多资源

The ontogeny of acute myeloid leukemia is a multistep process. It is driven both by features of the malignant clone itself as well as by environmental pressures, making it a unique process in each individual. The technological advancements of recent years has increased our understanding about the different steps that take place at the genomic level. It is now clear that malignant clones evolve, expand and change even during what seem to be clinically healthy or cured periods. This opens a wide window for new therapeutic and monitoring opportunities. Moreover, prediction and even early prevention have become possible goals to be pursued. The aim of this review is to shed light upon recent observations in leukemia evolution and their clinical implications. We present a critical view of these concepts in order to assist clinicians when interpreting results of the ever growing myriad of genomic diagnostic tests. We wish to help clinicians incorporate genetic tests into their clinical assessment and enable them to provide genetic counseling to their patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemia

Amos Tuval, Yardena Brilon, Hadas Azogy, Yoni Moskovitz, Dena Leshkowitz, Tomer M. Salame, Mark D. Minden, Perry Tal, Varda Rotter, Moshe Oren, Nathali Kaushansky, Liran Shlush

Summary: Pre-leukemic clones carrying DNMT3A mutations have inherent chemoresistance and selective advantage. They also have a dominant pseudo-mutant P53 conformation. Shifting the dynamic equilibrium in favor of the wild-type P53 conformation can eliminate dysfunctional cells.

HAEMATOLOGICA (2022)

Article Hematology

Pseudo-mutant P53 is a unique phenotype of DNMT3A- mutated pre-leukemia

Amos Tuval, Yardena Brilon, Hadas Azogy, Yoni Moskovitz, Dena Leshkowitz, Tomer M. Salame, Mark D. Minden, Perry Tal, Varda Rotter, Moshe Oren, Nathali Kaushansky, Liran Shlush

Summary: The study found that pre-leukemic hematopoietic stem/progenitor cells (preL-HSPC) carrying DNMT3A mutations have abnormal P53 conformation, which can be targeted with specific peptide treatment to eliminate the abnormal conformation, providing a new avenue for leukemia prevention.

HAEMATOLOGICA (2022)

Article Ophthalmology

Perceptual learning in contrast discrimination: The effect of contrast uncertainty

Y Adini, A Wilkonsky, R Haspel, M Tsodyks, D Sagi

JOURNAL OF VISION (2004)

暂无数据